Perioperative Atrial Fibrillation in Noncardiac Surgeries for Malignancies and One-Year Recurrence.


Journal

The Canadian journal of cardiology
ISSN: 1916-7075
Titre abrégé: Can J Cardiol
Pays: England
ID NLM: 8510280

Informations de publication

Date de publication:
11 2019
Historique:
received: 04 05 2019
revised: 08 07 2019
accepted: 09 07 2019
entrez: 5 11 2019
pubmed: 5 11 2019
medline: 14 5 2020
Statut: ppublish

Résumé

Perioperative atrial fibrillation (POAF) in noncardiac surgeries is common. However, it is unclear whether such atrial fibrillation (AF) recurs in the long term. This study was a prospective, single-center, observational study that included patients who underwent noncardiac surgeries for malignancies. Patients were followed up for 1 year to evaluate the incidence of AF, ischemic stroke, and mortality. An event-triggered recorder was used in patients with POAF. The incidences were compared according to the presence of POAF. Of 752 consecutive patients, 77 (10.2%) developed POAF and wore an event recorder for 19 (12-30) days. AF and ischemic stroke at 1 year were observed in 24 patients (31.1%) and 2 patients (2.6%) with POAF and 4 patients (0.6%) and 3 patients (0.4%) without POAF, respectively. Of the 24 patients with POAF and AF recurrence, 22 (92%) were asymptomatic. Anticoagulation was prescribed in 67 patients (87%) with POAF. Multivariate Cox regression analysis demonstrated that a higher AF recurrence rate in patients with POAF was associated with hypertension (hazard ratio, 2.79; 95% confidence interval, 1.06-7.38) and serum creatinine level (hazard ratio for 20 μmol/L increase, 2.32; 95% confidence interval, 1.16-4.62). AF recurs in approximately 30% of patients with POAF with malignancy in the subsequent year; most recurrences are asymptomatic.

Sections du résumé

BACKGROUND
Perioperative atrial fibrillation (POAF) in noncardiac surgeries is common. However, it is unclear whether such atrial fibrillation (AF) recurs in the long term.
METHODS
This study was a prospective, single-center, observational study that included patients who underwent noncardiac surgeries for malignancies. Patients were followed up for 1 year to evaluate the incidence of AF, ischemic stroke, and mortality. An event-triggered recorder was used in patients with POAF. The incidences were compared according to the presence of POAF.
RESULTS
Of 752 consecutive patients, 77 (10.2%) developed POAF and wore an event recorder for 19 (12-30) days. AF and ischemic stroke at 1 year were observed in 24 patients (31.1%) and 2 patients (2.6%) with POAF and 4 patients (0.6%) and 3 patients (0.4%) without POAF, respectively. Of the 24 patients with POAF and AF recurrence, 22 (92%) were asymptomatic. Anticoagulation was prescribed in 67 patients (87%) with POAF. Multivariate Cox regression analysis demonstrated that a higher AF recurrence rate in patients with POAF was associated with hypertension (hazard ratio, 2.79; 95% confidence interval, 1.06-7.38) and serum creatinine level (hazard ratio for 20 μmol/L increase, 2.32; 95% confidence interval, 1.16-4.62).
CONCLUSIONS
AF recurs in approximately 30% of patients with POAF with malignancy in the subsequent year; most recurrences are asymptomatic.

Identifiants

pubmed: 31679617
pii: S0828-282X(19)30479-9
doi: 10.1016/j.cjca.2019.07.008
pii:
doi:

Types de publication

Journal Article Observational Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1449-1456

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2019 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.

Auteurs

Satoshi Higuchi (S)

Department of Cardiology, Kyorin University School of Medicine, Tokyo, Japan; Department of Emergency and General Medicine, Kyorin University School of Medicine, Tokyo, Japan. Electronic address: sahiguchi-circ@umin.ac.jp.

Yusuke Kabeya (Y)

Division of General Internal Medicine, Department of Internal Medicine, Tokai University, Kanagawa, Japan; Department of Home Care Medicine, Sowa Hospital, Kanagawa, Japan.

Kenichi Matsushita (K)

Department of Cardiology, Kyorin University School of Medicine, Tokyo, Japan.

Nobuaki Arai (N)

Department of General Thoracic Surgery, Kyorin University School of Medicine, Tokyo, Japan.

Keisei Tachibana (K)

Department of General Thoracic Surgery, Kyorin University School of Medicine, Tokyo, Japan.

Ryota Tanaka (R)

Department of General Thoracic Surgery, Kyorin University School of Medicine, Tokyo, Japan.

Riken Kawachi (R)

Department of General Thoracic Surgery, Nihon University School of Medicine, Tokyo, Japan.

Hidefumi Takei (H)

Department of General Thoracic Surgery, Kyorin University School of Medicine, Tokyo, Japan; Division of Chest Surgery, Showa University School of Medicine, Tokyo, Japan.

Yutaka Suzuki (Y)

Department of Surgery, Kyorin University School of Medicine, Tokyo, Japan.

Masaharu Kogure (M)

Department of Surgery, Kyorin University School of Medicine, Tokyo, Japan.

Yorihisa Imanishi (Y)

Department of Otorhinolaryngology, Head and Neck Surgery, Kawasaki Municipal Kawasaki Hospital, Kawasaki, Japan.

Kiyoshi Moriyama (K)

Department of Anesthesiology, Kyorin University School of Medicine, Tokyo, Japan.

Masanori Sugiyama (M)

Department of Surgery, Kyorin University School of Medicine, Tokyo, Japan.

Tomoko Yorozu (T)

Department of Anesthesiology, Kyorin University School of Medicine, Tokyo, Japan.

Koichiro Saito (K)

Department of Otolaryngology-Head and Neck Surgery, Kyorin University School of Medicine, Tokyo, Japan.

Nobutsugu Abe (N)

Department of Surgery, Kyorin University School of Medicine, Tokyo, Japan.

Haruhiko Kondo (H)

Department of General Thoracic Surgery, Kyorin University School of Medicine, Tokyo, Japan.

Hideaki Yoshino (H)

Department of Cardiology, Kyorin University School of Medicine, Tokyo, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH